Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycin

Cláudia Gomes, Sandra Martínez-Puchol, Noemí Palma, Gertrudis Horna, Lidia Ruiz-Roldán, Maria J. Pons, Joaquim Ruiz

Resultado de la investigación: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

55 Citas (Scopus)

Resumen

From its introduction in 1952 onwards, the clinical use of macrolides has been steadily increasing, both in human and veterinary medicine. Although initially designed to the treatment of Gram-positive microorganisms, this antimicrobial family has also been used to treat specific Gram-negative bacteria. Some of them, as azithromycin, are considered in the armamentarium against Enterobacteriaceae infections. However, the facility that this bacterial genus has to gain or develop mechanisms of antibiotic resistance may compromise the future usefulness of these antibiotics to fight against Enterobacteriaceae infections. The present review is focused on the mechanisms of macrolide resistance, currently described in Enterobacteriaceae.

Idioma originalInglés
Páginas (desde-hasta)1-30
Número de páginas30
PublicaciónCritical Reviews in Microbiology
Volumen43
N.º1
DOI
EstadoPublicada - 2 ene. 2017

Huella

Profundice en los temas de investigación de 'Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycin'. En conjunto forman una huella única.

Citar esto